CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer.

CONCLUSION: Our results revealed that the presence of CIMP independently predicts poor OS in patients with stage IV CRC. PMID: 30540994 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30540994?dopt=Abstract

Source: Oncology - December 12, 2018 Category: Cancer & Oncology Authors: Chen KH, Lin LI, Tseng LH, Lin YL, Liau JY, Tsai JH, Liang JT, Lin BR, Cheng AL, Yeh KH Tags: Oncology Source Type: research